NCT00231335View on ClinicalTrials.gov

Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

July 31, 2007

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

escitalopram

Sponsors

Collaborators (1)

Forest Laboratories
All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Emory University

OTHER